Picture of Disruptive Pharma AB (publ) logo

DPHA — Disruptive Pharma AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: A1M Pharma Applies For Clinical Phase I Study

Jan 31 (Reuters) - A1M PHARMA AB  A1M.ST : 
    * A1M PHARMA SUBMITS APPLICATION TO THE SWEDISH MEDICAL 
PRODUCTS 
AGENCY TO CONDUCT CLINICAL PHASE I STUDY WITH ROSGARD 
 
Source text for Eikon:  ID:nBQNbVtMSf  
Further company coverage:  A1M.ST  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Disruptive Pharma AB (publ)

See all news